| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Skye Bioscience, Inc. | Director | Common Stock | 259,701 | $1,295,908 | $4.99 | 18 Nov 2024 | Direct |
| Skye Bioscience, Inc. | Director | Stock Option (Right to Buy) | 135,000 | $1,190 | $0.0170 | 24 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SKYE | Skye Bioscience, Inc. | 24 Feb 2025 | 1 | $0 | 4 | Director | 26 Feb 2025, 17:47 |
| SKYE | Skye Bioscience, Inc. | 15 Nov 2024 | 2 | -$432,061 | 4 | Director | 19 Nov 2024, 21:14 |
| SKYE | Skye Bioscience, Inc. | 28 Oct 2024 | 1 | $0 | 4 | Director | 30 Oct 2024, 20:29 |
| SKYE | Skye Bioscience, Inc. | 29 Feb 2024 | 2 | $0 | 4 | Director | 04 Mar 2024, 19:53 |
| SKYE | Skye Bioscience, Inc. | 06 Nov 2023 | 1 | $0 | 4 | Director | 06 Nov 2023, 20:29 |
| SKYE | Skye Bioscience, Inc. | 25 Aug 2023 | 1 | $0 | 4 | Director | 29 Aug 2023, 20:25 |
| SKYE | Skye Bioscience, Inc. | 18 Aug 2023 | 0 | $0 | 3 | Director | 22 Aug 2023, 18:19 |